Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 5.34 | 6.01 | 10.03 | 8.30 |
Depreciation/ Depletion | 1.70 | 1.57 | 1.99 | 0.92 |
Deferred Taxes | -6.66 | - | - | - |
Non- Cash Items | 4.38 | 2.87 | 2.00 | 2.43 |
Changesin Working Capital | -13.33 | -11.73 | -18.51 | -6.18 |
Cashfrom Operating Activities | -2.58 | -1.28 | -4.49 | 5.48 |
Capital Expenditures | -0.72 | -1.04 | -2.20 | -2.88 |
Other Investing Cash Flow Items Total | -0.98 | 1.49 | 0.00 | - |
Cashfrom Investing Activities | -1.70 | 0.44 | -2.20 | -2.88 |
Financing Cash Flow Items | -4.42 | -2.87 | -2.00 | -2.43 |
Issuance( Retirement)of Stock Net | 10.66 | 0.00 | 8.23 | - |
Issuance( Retirement)of Debt Net | -1.06 | 4.22 | 0.00 | -0.02 |
Cashfrom Financing Activities | 5.17 | 1.35 | 6.23 | -2.45 |
Net Changein Cash | 0.89 | 0.51 | -0.46 | 0.15 |
Cash Interest Paid | 4.38 | 2.87 | 2.00 | 2.43 |
Cash Taxes Paid | 1.33 | 2.28 | 3.59 | 1.66 |
Aarey Drugs & Pharmaceuticals Dividend Aarey Drugs & Pharmaceuticals Bonus Aarey Drugs & Pharmaceuticals News Aarey Drugs & Pharmaceuticals AGM Aarey Drugs & Pharmaceuticals Rights Aarey Drugs & Pharmaceuticals Splits Aarey Drugs & Pharmaceuticals Board Meetings Aarey Drugs & Pharmaceuticals Key Metrics Aarey Drugs & Pharmaceuticals Shareholdings Aarey Drugs & Pharmaceuticals Profit Loss Aarey Drugs & Pharmaceuticals Balance Sheet Aarey Drugs & Pharmaceuticals Q1 Results Aarey Drugs & Pharmaceuticals Q2 Results Aarey Drugs & Pharmaceuticals Q3 Results Aarey Drugs & Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks